Rxsight Inc (RXST) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Rxsight Inc

NASDAQ | RXST

15.57

USD

-0.64 (-3.95%)

AT CLOSE (AS OF Apr 4, 2025)

$656M

MARKET CAP

P/E Ratio

-0.71

EPS

$67

52 Week High

$14

52 Week Low

LIFE SCIENCES

Sector

RXST Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

RXST Technicals

Tags:

RXST Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$99M
Total Revenue	$140M
Cost Of Revenue	$142M
Costof Goods And Services Sold	$41M
Operating Income	-$37M
Selling General And Administrative	$101M
Research And Development	$34M
Operating Expenses	$136M
Investment Income Net	-
Net Interest Income	$9.5M
Interest Income	$9.5M
Interest Expense	$21K
Non Interest Income	$140M
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$3.6M
Income Before Tax	-$27M
Income Tax Expense	$50K
Interest And Debt Expense	$21K
Net Income From Continuing Operations	-$27M
Comprehensive Income Net Of Tax	-$27M
Ebit	-$27M
Ebitda	-$24M
Net Income	-$27M

Revenue & Profitability

Earnings Performance

RXST Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2024)

Field	Value (USD)
Total Assets	$319M
Total Current Assets	$294M
Cash And Cash Equivalents At Carrying Value	$17M
Cash And Short Term Investments	$237M
Inventory	$22M
Current Net Receivables	$30M
Total Non Current Assets	$25M
Property Plant Equipment	$12M
Accumulated Depreciation Amortization Ppe	$25M
Intangible Assets	-
Intangible Assets Excluding Goodwill	-
Goodwill	-
Investments	-
Long Term Investments	-
Short Term Investments	$221M
Other Current Assets	$4.5M
Other Non Current Assets	$360K
Total Liabilities	$37M
Total Current Liabilities	$26M
Current Accounts Payable	$4.5M
Deferred Revenue	$3.1M
Current Debt	$28K
Short Term Debt	$974K
Total Non Current Liabilities	$233K
Capital Lease Obligations	$106K
Long Term Debt	-
Current Long Term Debt	-
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$12M
Other Current Liabilities	$17M
Other Non Current Liabilities	$127K
Total Shareholder Equity	$281M
Treasury Stock	-
Retained Earnings	-$622M
Common Stock	$40K
Common Stock Shares Outstanding	$40M

yearly Cash Flow (As of Dec 31, 2024)

Field	Value (USD)
Operating Cashflow	-$17M
Payments For Operating Activities	$2.2M
Proceeds From Operating Activities	-
Change In Operating Liabilities	$946K
Change In Operating Assets	$16M
Depreciation Depletion And Amortization	$3.6M
Capital Expenditures	$5.4M
Change In Receivables	$9.8M
Change In Inventory	$5M
Profit Loss	-$27M
Cashflow From Investment	-$99M
Cashflow From Financing	$123M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	$21M
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$129M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$27M

yearly Income Statement (As of Dec 31, 2024)

Field	Value (USD)
Gross Profit	$99M
Total Revenue	$140M
Cost Of Revenue	$142M
Costof Goods And Services Sold	$41M
Operating Income	-$37M
Selling General And Administrative	$101M
Research And Development	$34M
Operating Expenses	$136M
Investment Income Net	-
Net Interest Income	$9.5M
Interest Income	$9.5M
Interest Expense	$21K
Non Interest Income	$140M
Other Non Operating Income	-
Depreciation	-
Depreciation And Amortization	$3.6M
Income Before Tax	-$27M
Income Tax Expense	$50K
Interest And Debt Expense	$21K
Net Income From Continuing Operations	-$27M
Comprehensive Income Net Of Tax	-$27M
Ebit	-$27M
Ebitda	-$24M
Net Income	-$27M

RXST Profile

Rxsight Inc Profile

Sector: LIFE SCIENCES

Industry: OPHTHALMIC GOODS

None

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	9.42%	-	776,312,724
NVDA	$101.80	-7.81%	$2.68T	338,769,412
INTC	$22.43	2.05%	$95.85B	242,972,129
F	$9.54	-6.01%	$39.53B	220,270,980
LCID	$2.32	-3.33%	$7.67B	212,604,854

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$159.82	2.87%	$399.65B	13,249,313
PG	$172.39	1.71%	$399.61B	9,393,270
ABBV	$201.64	-1.73%	$364.89B	7,593,125
NVO	$67.10	-1.67%	$308.32B	8,822,513
AZN	$73.92	2.35%	$225.70B	9,148,835

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
ICCT	$4.23	104.35%	$9.78M	175,372,941
MRM	$0.69	87.76%	$2.91M	54,062,078
PTIX	$0.42	84.14%	$4.04M	180,233,724
OSRH	$2.47	68.03%	$40.06M	89,499,750
OMQS	$0.06	62.16%	$1.50M	59,659

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	21,941,899
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
MMV	$0.48	-51.02%	$11.90M	1,568,644